DGAP-Adhoc: Chairman of the Supervisory Board of Evotec to resign from office effective as of the end of the Annual General Meeting on 15 June 2021
DGAP-Ad-hoc: Evotec SE / Key word(s): Miscellaneous
Chairman of the Supervisory Board of Evotec to resign from office effective as of the end of the Annual General Meeting on 15 June 2021
23-Apr-2021 / 13:03 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014
Chairman of the Supervisory Board of Evotec to resign from office effective as of the end of the Annual General Meeting on 15 June 2021
Hamburg, Germany - Evotec SE (Frankfurt Stock Exchange; EVT, MDAX/TecDAX, ISIN: DE0005664809, WKN 566480) announces that today the Chairman of the Supervisory Board, Prof. Dr Wolfgang Plischke, has informed the Company of his decision to resign from his office in the Supervisory Board of Evotec SE effective as of the end of the Annual General Meeting on 15 June 2021 due to personal reasons. Prof. Dr Plischke has been serving in the Supervisory Board as Chairman since 2014.
Contact:
Dr Werner Lanthaler, Chief Executive Officer
Evotec SE
Manfred Eigen Campus
Essener Bogen 7
22419 Hamburg, Germany
Phone: +49.(0)40.560 81-242
Email: [email protected]
23-Apr-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
|
Language: |
English |
Company: |
Evotec SE |
|
Manfred Eigen Campus / Essener Bogen 7 |
|
22419 Hamburg |
|
Germany |
Phone: |
+49 (0)40 560 81-0 |
Fax: |
+49 (0)40 560 81-222 |
E-mail: |
[email protected] |
Internet: |
www.evotec.com |
ISIN: |
DE0005664809 |
WKN: |
566480 |
Indices: |
MDAX, TecDAX |
Listed: |
Regulated Market in Berlin, Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: |
1187983 |
|
End of Announcement |
DGAP News Service |
1187983 23-Apr-2021 CET/CEST
Die wichtigsten Finanzdaten auf einen Blick
|
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023e |
Umsatzerlöse1 |
257,63 |
375,41 |
446,44 |
500,92 |
618,03 |
751,45 |
835,00 |
EBITDA1,2 |
57,22 |
95,46 |
123,14 |
51,77 |
101,65 |
102,51 |
122,00 |
EBITDA-Marge3 |
22,21 |
25,43 |
27,58 |
10,33 |
16,45 |
13,64 |
|
EBIT1,4 |
37,50 |
77,46 |
62,59 |
48,52 |
41,00 |
20,85 |
0,00 |
EBIT-Marge5 |
14,56 |
20,63 |
14,02 |
9,69 |
6,63 |
2,78 |
0,00 |
Jahresüberschuss1 |
24,00 |
84,06 |
37,23 |
6,25 |
215,51 |
-175,66 |
0,00 |
Netto-Marge6 |
9,32 |
22,39 |
8,34 |
1,25 |
34,87 |
-23,38 |
0,00 |
Cashflow1,7 |
10,83 |
156,24 |
42,22 |
44,72 |
122,24 |
203,11 |
0,00 |
Ergebnis je Aktie8 |
0,16 |
0,46 |
0,25 |
0,04 |
1,30 |
-0,99 |
-0,50 |
Dividende8 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
Quelle: boersengefluester.de und Firmenangaben
Geschäftsbericht 2022 - Kostenfrei herunterladen.
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de
Wirtschaftsprüfer: BDO
|
INVESTOR-INFORMATIONEN |
©boersengefluester.de |
Evotec |
WKN |
Kurs in € |
Einschätzung |
Börsenwert in Mio. € |
566480 |
13,260 |
Halten |
2.354,21 |
KGV 2025e |
KGV 10Y-Ø |
BGFL-Ratio |
Shiller-KGV |
19,50 |
34,95 |
0,56 |
74,92 |
KBV |
KCV |
KUV |
EV/EBITDA |
2,06 |
11,59 |
3,13 |
23,84 |
Dividende '22 in € |
Dividende '23e in € |
Div.-Rendite '23e in % |
Hauptversammlung |
0,00 |
0,00 |
0,00 |
10.06.2024 |
Q1-Zahlen |
Q2-Zahlen |
Q3-Zahlen |
Bilanz-PK |
22.05.2024 |
14.08.2024 |
08.11.2023 |
24.04.2024 |
Abstand 60Tage-Linie |
Abstand 200Tage-Linie |
Performance YtD |
Performance 52 Wochen |
-3,18% |
-25,40% |
-37,69% |
-23,77% |
|
|